PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
6 hedge funds and large institutions have $737K invested in PAVmed Inc. Series Z Warrant in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
33% less funds holding
Funds holding: 9 → 6 (-3)
45% less capital invested
Capital invested by funds: $1.34M → $737K (-$601K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$11.9K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$6.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$386K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19K |
| 3 |
VF
Virtu Financial
New York
|
-$14K |
PAVMZ Hedge Fund Activity: Q3 2020 in Review
6 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q3 2020, worth a combined $737K — down 45% from $1.34M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PAVMZ and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Levin Capital Strategies, adding an estimated $11.9K. The largest seller was Sabby Management, cutting an estimated $386K.
- 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q3 2020, down from 9 in Q2 2020.
- Funds reported $737K of PAVmed Inc. Series Z Warrant stock for Q3 2020, down 45% quarter-over-quarter.
- 0 funds opened new PAVmed Inc. Series Z Warrant positions in Q3 2020 and 3 closed out, a net change of -3 holders.
- The largest PAVmed Inc. Series Z Warrant buyer in Q3 2020 was Levin Capital Strategies, an estimated $11.9K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q3 2020 was Sabby Management, an estimated $386K sold.
Based on aggregated 13F filings for Q3 2020.